Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04875715 · ClinicalTrials.gov registry record · Phase 4
Prospective Evaluation of Topical Almond Oil vs Hydroquinone
A Phase 4 study of Skin Pigmentation, sponsored by University of California, Davis.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04875715: Recruiting Phase 4 study of Skin Pigmentation, sponsored by University of California, Davis.
NCT04875715 is a Phase 4 study of Skin Pigmentation that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04875715, a Phase 4 study of Skin Pigmentation, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to analyze facial pigmentation and skin microbiome changes after topical almond oil application, compared to the use of topical hydroquinone.
Primary Outcome
Facial images will be obtained and analyzed with the BTBP image analysis system
Conditions Studied
Interventions
- OTHER Almond Oil
- DRUG Hydroquinone Topical
Study Locations (1)
California
- UC Davis Department of Dermatology, Clinical Trials Unit - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2026-08-01 |
| Phase | Phase 4 |
What NCT04875715 shows while recruiting
NCT04875715 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Skin Pigmentation appearing as the primary indexed condition, and to 2 interventions - of which Almond Oil is the first listed.
NCT04875715 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04875715 about?
NCT04875715 is a clinical study titled "Prospective Evaluation of Topical Almond Oil vs Hydroquinone". The purpose of this study is to analyze facial pigmentation and skin microbiome changes after topical almond oil application, compared to the use of topical hydroquinone.
What is the current status of trial NCT04875715?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2021-07-01. Estimated completion is 2026-08-01.
What conditions does trial NCT04875715 study?
This clinical trial studies the following conditions: Skin Pigmentation.
What interventions are being tested in trial NCT04875715?
The interventions under investigation include: Almond Oil (OTHER), Hydroquinone Topical (DRUG).
Who is sponsoring clinical trial NCT04875715?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04875715 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Pigmentation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04875715's enrollment target sits among peer trials
50 1255th of 2000 higher than 679 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI